Compare Nasdaq100 ETF (QQQ) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nasdaq100 ETF vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Nasdaq100 ETF trades at $754.08 (market cap $508.48B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.27 (market cap $2.28B). The key difference: Nasdaq100 ETF is far larger — about 223× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Nasdaq100 ETF is trading nearer its 52-week high, SELLAS Life Sciences Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals.
| QQQ | SLS | |
|---|---|---|
Market Cap | $508.48B | $2.28B |
Volume | 25,184,775 | 3,128,960 |
52-Week High | $759.66 | $15.46 |
52-Week Low | $558.34 | $1.39 |
Typical Hold Time | 162 Days | — |
Sector | — | Health |
Enterprise Value | — | $2.15B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
QQQ trades at $757.73, down 0.25% on the day, with a bullish technical signal from moving averages but bearish oscillators. Analyst sentiment is split evenly between buy and sell recommendations. The ETF's recent all-time high and concentrated tech exposure drive both optimism and valuation concerns amid AI-driven market trends.
The outlook hinges on tech sector performance and interest rate sensitivity. Opportunities include AI growth tailwinds, while risks involve high valuations and Fed policy impacts. A dividend of $0.75 is scheduled for October 2026, adding income appeal but not immediate catalyst.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Nasdaq100 ETF
The ETF is designed to track the performance of the securities and the stocks in the NASDAQ-100 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on QQQ →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
